ARPA-H Smart Band-Aid to Measure Chronic Pain in Women
Recruiting now
Conditions studied: Chronic Pain
In brief
The goal of this clinical trial is to test whether a minimally invasive microneedle patch, called the A-Band (Smart Band-aid), worn on the arm (monitoring key biomarkers in interstitial fluid) and a commercial smartwatch can accurately correlate with self-reported pain in women with chronic pain. A secondary purpose of the study is to identify demographic and clinical variables impacting pain measurement. The main questions that this study aims to answer are: * What is the correlation between AI-adjusted pain scores, based on biomarkers and validated tools, and self-reported pain scores? * What influence do demographic and clinical information have in the correlation of these pain scores? Researchers will compare data from these tools with self-reported pain scores in women with chronic pain and healthy women. Participants will: * Be a part of the study for approximately 8 days * Attend 2-3 in-person visits at the applicable clinical center over approximately one week * Wear a Smart Band-Aid (A-Band) at least twice per day for a week, with each application lasting up to 90 minutes * Complete questionnaires regarding medical history, pain information, mental health, sleep, and demographic data * Record daily pain scores * Wear a smartwatch for one week which will collect biophysical data (heart rate, skin response, etc.) * Collect daily saliva samples * Have blood drawn by medical staff at 2 in-person visits
Key facts
- Study ID
- NCT06994988
- Run by
- Northwestern University
- People needed
- 115
- Starts
- 2026-07-01
- Expected to finish
- 2027-04-23
- Last updated by the study team
- 2026-06-15
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- For chronic pain group:
- Female, 18 years or older.
- Diagnosis of chronic pain condition (e.g., fibromyalgia, chronic lower back pain) as determined by the Principal Investigator.
- Ability to provide informed consent.
- For healthy controls:
- Female, 18 years or older.
- No history of chronic pain.
- No significant or poorly controlled medical conditions as determined by the Principal Investigator and exclusion criteria.
- No significant active, poorly controlled psychological conditions as determined by the Principal Investigator and exclusion criteria.
- Ability to provide informed consent.
- Exclusion Criteria (both groups):
- Pregnant or breastfeeding women.
- Substance abuse or psychiatric disorders that interfere with study participation.
- Major medical conditions (such as severe cardiovascular, neurological, cancer or autoimmune diseases) or psychological conditions (e.g., active, poorly-controlled depression, anxiety disorder, PTSD, substance use disorder) that interfere with study participation.
- Possibility of secondary financial gain from participation
- Interventional pain treatment(s) within 6 weeks of baseline (injection, epidural, etc.)
- Current opioid usage or usage within 2 weeks of baseline
Where it is running
- Northwestern University Feinberg School of Medicine — Chicago, Illinois, United States (enrolling)
- Walter Reed National Military Medical Center — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.